Pediatrics
Conference Coverage
First-in-kind study parsed risks of central lines in children
SAN DIEGO - Rising rates of pediatric venous thromboembolism in the United States underscore the need to carefully weigh the risks and benefits of...
Conference Coverage
VIDEO: SPIN tests hydroxyurea to prevent pediatric stroke in sickle cell disease
SAN DIEGO - Whether hydroxyurea can avert a first stroke in children with sickle cell disease is a question that may be answered by a soon-to-be-...
Conference Coverage
VIDEO: Novel microcapsules show promise in hemophilia A with inhibitory antibodies
SAN DIEGO – Novel microcapsules loaded with factor VIII outperformed systemic factor VIII infusions in models of hemophilia A with inhibitory...
From the Journals
Adding metronomic chemo provides no benefit to MAP for osteosarcoma
Adding low-dose metronomic chemotherapy (oral cyclophosphamide and methotrexate) to standard methotrexate, adriamycin, and platinum (MAP)...
News
Team develops model of common infant ALL
Photo by Petr Kratochvil After trying for nearly 2 decades, researchers have created a mouse model of t(4;11) pro-B acute lymphoblastic leukemia...
News
Panobinostat might treat high-risk ALL subtype
Photo courtesy of Novartis Researchers say they have identified a high-risk subtype of acute lymphoblastic leukemia (ALL) that may respond to...
From the Journals
Cancer type, age at time of diagnosis implicated in risk of CVD-related deaths
A clearer picture of the dangers posed by cardiotoxicity is emerging after U.K. researchers found that survivorship rates among those diagnosed...
News
Vector may make gene therapy safer
Photo courtesy of Washington State University Spokane Using modified foamy retroviral vectors to deliver gene therapy may reduce the risk of...
News
Team identifies genetic hallmarks of B-ALL subtype
Photo courtesy of St.
Feature
CMS offering educational webinars on MACRA
The Centers for Medicare & Medicaid Services is offering a pair of webinars aimed at helping physicians navigate the new regulation that...
News
Immunotherapy produces CRs in kids with rel/ref ALL
Of the patients who received the recommended dosage of blinatumomab, 39% achieved a CR within the first 2 treatment cycles. And 52% of these...